$92.37
Value $61.7B
CRH and DRD stock compared: price, dividend, valuation and results, from SEC filings.
$92.37
Value $61.7B
$22.04
Value $1.9B
CRH (CRH) has a market value of $61.7B and DRDGOLD (DRD) $1.9B. Over the last year, with dividends, CRH moved -16.6% and DRD -17.0%. The P/E is 17.4 for CRH and 15.1 for DRD. Dividend yield: CRH 1.69%, DRD none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CRH$61.7B
DRD$1.9B
CRH is 32 times DRD
Revenue, 12 months
CRH$39.0B
DRD$445M
CRH is 88 times DRD
Net income, 12 months
CRH$3.6B
DRD$127M
CRH is 28 times DRD
Operating margin
CRH13.7%
DRD37.0%
23.3 points apart
ROIC
CRH9.2%
DRD25.9%
16.7 points apart
P/E
CRH17.4
DRD15.1
CRH is 1.2 times DRD
Dividend yield
CRH1.7%
DRD0.0%
1.7 points apart
5-year return
CRH+108.8%
DRD+172.8%
64.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CRH+108.8%
DRD+172.8%
| Period | CRHWith dividends | DRDWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -16.6%Price -17.8% | -17.0%Price -20.1% |
| 3 years since November 13, 2023 | +64.9%+18.1% a yearPrice +56.0% | +198.2%+43.9% a yearPrice +176.4% |
| 5 years since November 12, 2021 | +108.8%+15.9% a yearPrice +82.7% | +172.8%+22.2% a yearPrice +126.4% |
| 10 years since November 16, 2016 | +258.7%+13.6% a yearPrice +176.2% | +635.3%+22.1% a yearPrice +416.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CRHCRHDRDDRDGOLD
| Price | $92.37 | $22.04 |
|---|---|---|
| Market value | $61.7B | $1.9B |
| Enterprise value (EV) | $76.9B | $1.8B |
| P/E | 17.4 | 15.1 |
| P/E, 5-year median | 16.0 | 9.1 |
| P/B | 2.5 | 3.8 |
| EV/EBIT | 14.4 | 11.1 |
| Free cash flow yield | 4.1% | 3.7% |
| Revenue, 12 months | $39.0B | $445M |
|---|---|---|
| Net income, 12 months | $3.6B | $127M |
| Free cash flow, 12 months | $2.5B | $71M |
| Earnings per share, 12 months | $5.32 | $1.46 |
| Revenue growth, year on year | 5.3% | 26.3% |
| Revenue growth a year, past | +7.7%over 5 years | +13.5%over 5 years |
| EPS growth a year, past | -47.8%over 5 years | -49.8%over 5 years |
| Gross margin | 36.2% | 39.7% |
|---|---|---|
| Operating margin | 13.7% | 37.0% |
| Net margin | 9.2% | 28.5% |
| ROIC | 9.2% | 25.9% |
| ROE | 15.0% | 25.3% |
| Cash | $5.1B | $74M |
|---|---|---|
| Total debt | $21.6B | $982.1K |
| Net debt / EBITDA | 2.0 | -0.4 |
| Interest cover | 6.3× | – |
| Dividend yield | 1.7% | – |
|---|---|---|
| Dividend per share, 12 months | $1.56 | – |
| Dividend growth a year, past | – | -14.2%over 4 years |
| Buyback yield | 1.9% | – |
| Shareholder yield | 3.6% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, CRH ($61.7B) is about 32.4 times DRDGOLD ($1.9B), at today's prices.
Since November 16, 2016, CRH's price moved +176.2% and DRD's +416.7%. With dividends: CRH +258.7% (+13.6% a year), DRD +635.3% (+22.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.69% for CRH and none for DRDGOLD. Over the last twelve months they paid $1.56 and – per share.
At today's price, the P/E is 17.4 for CRH and 15.1 for DRD. The median of the last five years was 16.0 and 9.1, which shows where each stands against its own past.
Over the last twelve months, the net margin was 9.2% for CRH and 28.5% for DRDGOLD, and the operating margin 13.7% and 37.0%. Revenue was $39.0B and $445M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.